When it comes to CLL/SLL treatment, what’s the difference between BTK inhibitors and BCL-2 inhibitors? Understanding how these treatment approaches work and how they fit into the treatment…
BTK degrader BGB-16673 reduced tumor burden in 85% of patients from a high-risk, hard-to-treat group with relapsed / refractory CLL. Dr. Stephan Stilgenbauer from Ulm University and colleagues…
NEW YORK (Reuters Health) – Although capsule endoscopy (PillCam COLON Capsule; Given Imaging) provides visualization of the colonic mucosa, it is not as sensitive as standard colonoscopy for…
A new tool in the fight against Barrett’s Esophagus shows promise. A recent study by Dr. Nicholas Shaheen, director of the University of North Carolina Center for Functional…
NEW YORK (Reuters Health) – Transvaginal sonography (TVS) is superior to symptom analysis for detecting ovarian cancer, while symptom analysis is better able to distinguish benign tumors, according…
NEW YORK (Reuters Health) – New research suggests that regardless of how hormone therapy is given, it increases the risk of ovarian cancer. “Our study suggests an increased…
July 14, 2009 (Portland, Ore.) – One in eight women develop breast cancer in their lifetimes. Although regular mammograms can reduce breast cancer deaths by more than 30…
NEW YORK (Reuters Health) – A further analysis of data from the Women’s Health Initiative (WHI) trials indicates that the risks of hormone therapy still generally outweigh the…
NEW YORK (Reuters Health) – Both obesity and type 2 diabetes, owing to their harmful effects on adipocytokines and inflammatory mediators, contribute to increased breast cancer risk in…
Miguel Materin, MD, Assistant Professor of Ophthalmology, Director of the Ocular Oncology Section, Yale University School of Medicine, discusses eye tumors ranging from benign to malignant ophthalmic cancers.…
Jimmy K. Lee, MD, Director of the Cornea and Refractive Surgery Section, Yale Eye Center, discusses dry eye treatment, including lubricant drops, cyclosporin and plugging the drainage tube…
NEW YORK (Reuters Health) – Patients with early (stage I and IIA) colon cancer derive similar benefits from intensive postoperative surveillance as those with late stage IIB and…
